Clinical ophthalmology (Auckland, N.Z.)最新文献

{"title":"Validation of a Novel Low-Cost Glaucoma Risk Calculator for Community-Based Screening in High-Risk Populations.","authors":"Kara Grimes, Chisom T Madu, Carena Carrington, Daniel Laroche","doi":"10.2147/OPTH.S500509","DOIUrl":"10.2147/OPTH.S500509","url":null,"abstract":"<p><strong>Purpose: </strong>To assess the validity of a novel, low-cost glaucoma screening calculator in determining glaucoma risk in high-risk New York communities.</p><p><strong>Patients and methods: </strong>This prognostic community-based study was conducted in New York City neighborhoods from 2022 to 2024 among participants aged 40 years and older. Glaucoma screenings were held at community gatherings including local fairs, senior citizen homes, places of worship, and in the lobby of medical offices. The screenings were conducted by trained non-physician medical personnel comprised medical students and medical assistants working under physician supervision. Participants' intraocular pressure (IOP) and central corneal thickness (CCT) were measured in both eyes with a handheld tonometer and pachymeter, respectively. Participants then completed a comprehensive eye exam by an ophthalmologist to confirm glaucoma status. Statistical analysis was completed using MedCalc version 22.023 (MedCalc Software Ltd. Ostend, Belgium) with 95% confidence intervals.</p><p><strong>Results: </strong>Of the 823 study participants, 716 (mean age 62.9 ± 11.9 years) were eligible to participate and completed the comprehensive follow-up exam. 68% identified as Black, 6.7% identified as Hispanic/Latino, and 52.5% identified as female. The Laroche glaucoma calculator had a sensitivity of 93.5% (CI 89.1-96.5%), specificity of 91.3% (CI 88.5-93.6%), positive predictive value of 80.5% (CI 75.7-84.6%), negative predictive value of 97.3% (CI 95.5-98.4%) and accuracy of 91.9% (CI 89.6-93.8%).</p><p><strong>Conclusion: </strong>The Laroche glaucoma calculator shows high sensitivity, specificity, positive predictive value, negative predictive value, and accuracy using affordable screening methods to determine glaucoma risk.</p>","PeriodicalId":93945,"journal":{"name":"Clinical ophthalmology (Auckland, N.Z.)","volume":"19 ","pages":"357-369"},"PeriodicalIF":0.0,"publicationDate":"2025-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11804874/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143383794","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Corneal Topographic Changes Due to Pediatric Epiblepharon Surgery.","authors":"Jun Shindo, Nozomi Matsumura, Jutaro Nakamura, Mizuki Asano, Tomoko Ohno, Nobuhisa Mizuki","doi":"10.2147/OPTH.S503661","DOIUrl":"10.2147/OPTH.S503661","url":null,"abstract":"<p><strong>Purpose: </strong>This study aimed to investigate changes in corneal morphology following pediatric lower-lid epiblepharon surgery using a topographic modeling system 5 (TMS-5^®).</p><p><strong>Patients and methods: </strong>A randomized controlled trial compared two surgical interventions for pediatric epiblepharon: incisional (modified Hotz procedure with lid margin splitting) and nonincisional. Corneal topography analysis using the TMS-5^® served as an outcome measure. The study included 89 eyes from 50 children aged 3-12 years (mean age, 7.5 ± 2.4 years) diagnosed with moderate epiblepharon. Patients were randomly assigned to the incisional (45 eyes from 25 patients) or nonincisional (44 eyes from 25 patients) groups. Parameters including surface regularity index (SRI), Standard Deviation of Corneal Power (SDP), Irregular Astigmatism Index (IAI), and corneal astigmatism (CYL) were evaluated. The positive rate of Keratoconus Screening System (Keratoconus Index [KCI] and Keratoconus Severity Index [KSI]) was assessed.</p><p><strong>Results: </strong>The 6-month postoperative mean changes in corneal astigmatism were -0.34 ± 0.96 D (p = 0.012) and -0.21 ± 0.67 D (p = 0.22) in the incisional and nonincisional groups, respectively. Corneal astigmatism parameters significantly improved following both surgical procedures (p < 0.01). Preoperatively, 14.6% and 28.1% of patients were suspected of keratoconus using KCI and KSI, respectively, with a significantly reduced postoperative suspicion positivity rate (p < 0.01).</p><p><strong>Conclusion: </strong>Corneal astigmatism significantly improved in the incisional group. Both surgical methods improved the postoperative corneal surface smoothness, corneal refractive power variability, and irregular astigmatism. Patients with epiblepharon were occasionally suspected of keratoconus when assessed with TMS, with a higher frequency indicated by KSI.</p>","PeriodicalId":93945,"journal":{"name":"Clinical ophthalmology (Auckland, N.Z.)","volume":"19 ","pages":"349-356"},"PeriodicalIF":0.0,"publicationDate":"2025-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11806347/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143383715","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Screening for Occult Macular Pathology Prior to Cataract Surgery Using Optical Coherence Tomography.","authors":"Yousef A Fouad, Amr Mohamed ElGwaily, Yasmine Maher Shaaban","doi":"10.2147/OPTH.S507995","DOIUrl":"10.2147/OPTH.S507995","url":null,"abstract":"<p><strong>Purpose: </strong>To study the prevalence of occult macular pathology using optical coherence tomography (OCT) during the preoperative evaluation for cataract surgery and associated risk factors.</p><p><strong>Methods: </strong>A retrospective analysis of patients' medical records and imaging. Adult patients who underwent cataract extraction who had normal preoperative fundoscopic examination and available preoperative OCT imaging were included.</p><p><strong>Results: </strong>The analysis included 121 eyes belonging to 121 patients. The prevalence of occult macular pathology was 21.5%, with the most common being interface abnormalities (8.3% of the eyes), drusen (4.1%), and diabetic macular edema (4.1%). Visually significant pathologies were noted in 6.6% of the eyes. Occult macular pathology was rare in patients aged less than 50 years (4.5%) and common among patients 70 years of age or older (43.3%). The most significant predictors of occult macular pathology were advanced age (OR: 1.06, p = 0.033) and diabetes mellitus (OR: 6.79, p = 0.002).</p><p><strong>Conclusion: </strong>Relying on fundoscopic evaluation alone would miss 1 in 5 eyes with occult macular pathology and 1 in 15 with pathologies that would alter the visual outcome. Preoperative OCT screening prior to cataract surgery should be considered, especially in patients with advanced age and diabetes mellitus.</p>","PeriodicalId":93945,"journal":{"name":"Clinical ophthalmology (Auckland, N.Z.)","volume":"19 ","pages":"317-324"},"PeriodicalIF":0.0,"publicationDate":"2025-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11794039/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143257649","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Update on Surgical Techniques Best Practices to Optimize Outcomes Following Gel Stent Implantation.","authors":"Vanessa Vera, Arsham Sheybani, Joseph F Panarelli, Davinder S Grover, James Lee, Earl Randy Craven, Thomas W Samuelson, Iqbal Ike K Ahmed","doi":"10.2147/OPTH.S487718","DOIUrl":"10.2147/OPTH.S487718","url":null,"abstract":"<p><p>The XEN®45 Glaucoma Treatment System (gel stent; Allergan, an AbbVie company, Irvine, CA, USA) is a minimally invasive bleb-forming surgical device that was originally approved to lower intraocular pressure by diverting the aqueous humor from the anterior chamber to the subconjunctival space (like trabeculectomy) following ab-interno placement. Since approval of the gel stent in multiple countries, the implantation technique has evolved considerably, being performed ab interno or ab externo with open or closed conjunctiva, based on patients' needs and/or surgeons' preferences. Additional technical variations that can facilitate gel stent placement and/or improve outcomes have also emerged. This article aims to increase awareness of these developments to facilitate informed decision-making and improve surgical success and outcomes for patients.</p>","PeriodicalId":93945,"journal":{"name":"Clinical ophthalmology (Auckland, N.Z.)","volume":"19 ","pages":"325-347"},"PeriodicalIF":0.0,"publicationDate":"2025-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11794994/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143257652","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comparison of IMO vifa24plus(1-2) and Humphrey Field Analyzer 24-2.","authors":"Yuki Takagi, Ryo Asano, Kanna Yamashita, Yukihiro Sakai, Sho Yokoyama, Kei Ichikawa, Kazuo Ichikawa","doi":"10.2147/OPTH.S506059","DOIUrl":"10.2147/OPTH.S506059","url":null,"abstract":"<p><strong>Purpose: </strong>This study aimed to compare the results of the IMO vifa 24plus(1-2) and HFA 24-2 visual field tests.</p><p><strong>Patients and methods: </strong>We included 52 patients (104 eyes) with glaucoma who visited Chukyo Eye Clinic between June 2023 and March 2024. On the same day, the HFA 24-2 test using the Swedish Interactive Threshold Algorithm Standard and the IMO vifa 24plus(1-2) test using the Ambient Interactive Zippy Estimated strategy were performed. A Wilcoxon signed-rank test was used to compare fixation, false positives, false negatives, and total test time for both eyes between the HFA and IMO vifa tests. Only eyes with reliable test results were selected, and the visual field index (VFI), mean deviation (MD), and pattern standard deviation (PSD) were examined using Spearman's rank correlation coefficient and the Wilcoxon signed-rank test.</p><p><strong>Results: </strong>The test times for the HFA 24-2 and IMO vifa 24plus(1-2) were 716.83±118.80 and 628.75±142.70 s, respectively, with the IMO vifa being significantly shorter (P<0.001). For fixation, the results were 15.85±16.57% and 11.09±15.20%, with significantly better fixation in the IMO vifa (P<0.0001). False positives and negatives were 4.52±5.19 / 4.14±6.85% and 4.97±7.99 / 5.47±7.86%, respectively, with no significant differences, though the IMO vifa showed a slightly higher trend (P=0.980, 0.056). In eyes with reliable results, the HFA 24-2 and IMO vifa 24plus(1-2) outcomes were as follows: MD (-6.45±7.23, -6.85±7.35, P=0.724), PSD (7.13±4.75, 7.49±4.87, P=0.061), VFI (80.86±21.61, 80.86±21.74, P=0.644). The Spearman rank correlation coefficients between the HFA 24-2 and IMO vifa 24plus(1-2) were MD: 0.938, PSD: 0.949, VFI: 0.932 (all P<0.001).</p><p><strong>Conclusion: </strong>The IMO vifa demonstrates a very high correlation with HFA and allows for a shorter examination time. Fixation errors are significantly improved compared to HFA, while there is no significant difference in false positives or false negatives.</p>","PeriodicalId":93945,"journal":{"name":"Clinical ophthalmology (Auckland, N.Z.)","volume":"19 ","pages":"301-307"},"PeriodicalIF":0.0,"publicationDate":"2025-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11789514/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143124152","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Visual Outcomes and Patient Satisfaction of Two Continuous Range of Vision Intraocular Lenses.","authors":"J Morgan Micheletti, Brad Hall, Hayden G Smiley, William J Langston","doi":"10.2147/OPTH.S504090","DOIUrl":"10.2147/OPTH.S504090","url":null,"abstract":"<p><strong>Purpose: </strong>To determine if visual outcomes with PanOptix are non-inferior to visual outcomes with Synergy.</p><p><strong>Methods: </strong>This was an ambispective, single center, comparative, bilateral, observational study. Patients received bilateral implantation with either PanOptix or Synergy intraocular lenses (IOLs) and were enrolled at least 5 months after surgeries. Patients with postoperative spherical equivalent ± 0.50D and astigmatism ≤ 0.75D in both eyes were enrolled. Postoperatively, patients were tested for binocular uncorrected and distance corrected visual acuities at distance, intermediate (60cm), and near (40cm and 33cm), binocular defocus curve, and were administered questionnaires about quality of vision (QUVID) and spectacle independence (IOLSAT).</p><p><strong>Results: </strong>A total of 230 subjects completed the study, 153 in the PanOptix group and 77 in the Synergy group. Non-inferiority of visual acuities were confirmed for all testing distances, with and without distance correction in place. No significant differences were observed for the binocular defocus curves (p > 0.05). Severity of starburst, halo, and glare were rated as \"None\" in 65% (98/150), 38% (58/152), and 48% (72/151) of subjects with the PanOptix Group, compared to 49% (37/76), 38% (29/77), and 55% (42/77) for the Synergy Group, respectively. The percentage of patients \"Satisfied\" or \"Very Satisfied\" with their vision was 89% (136/153) in the PanOptix group and 94% (72/77) in the Synergy group.</p><p><strong>Conclusion: </strong>The results of this study suggest excellent visual acuities at distance, intermediate, and near, high spectacle independence, and high patient satisfaction with both the PanOptix and Synergy IOLs. The incidence of starbursts and blurred vision, as well as visual acuities at extreme near (33 cm), may be higher with the Synergy IOL.</p>","PeriodicalId":93945,"journal":{"name":"Clinical ophthalmology (Auckland, N.Z.)","volume":"19 ","pages":"309-316"},"PeriodicalIF":0.0,"publicationDate":"2025-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11787775/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143082608","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Clinical Evaluation of Faricimab in Real-World Diabetic Macular Edema in India- A Multicenter Observational Study.","authors":"Debdulal Chakraborty, Sudipta Das, Aniruddha Maiti, Tushar Kanti Sinha, Arnab Das, Jay Sheth, Subhendu Kumar Boral, Soumen Mondal, Krishnendu Nandi","doi":"10.2147/OPTH.S502033","DOIUrl":"10.2147/OPTH.S502033","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate the efficacy of faricimab in real-world clinical settings in India for treating diabetic macular edema (DME) in treatment-naïve and recalcitrant eyes.</p><p><strong>Patients and methods: </strong>This retrospective study involved 39 eyes (16 treatment-naive and 23 recalcitrant) treated with intravitreal faricimab at four centers in India. Patients received three monthly loading doses followed by a pro-re-nata regimen, with outcomes measured for best-corrected visual acuity (BCVA), central macular thickness (CMT), intraretinal fluid (IRF), subretinal fluid (SRF), and hyperreflective foci (HRF).</p><p><strong>Results: </strong>Significant improvements in BCVA were observed in both treatment-naïve and recalcitrant groups, with greater gains in the naïve group (p<0.001). Overall, BCVA improved from 0.48 logMAR to 0.27 logMAR (<i>P</i><0.001), and 59% of eyes gained more than 10 ETDRS letters and 41% gaining >15 ETDRS letters. Both groups showed significant reduction in CMT, with the naïve group achieving greater reduction (<i>P</i><0.001). The overall CMT reduction was statistically significant at 6 months (<i>P</i><0.001). Resolution of IRF and SRF was achieved in both groups, with SRF reducing from 82.1% to 20.5% (<i>P</i><0.001) and IRF from 87.2% to 17.9% (<i>P</i><0.001). Significant reductions in HRF were also observed across both inner (<i>P</i><0.001) and outer retinal layers (<i>P</i><0.001). No ocular or systemic adverse events were reported.</p><p><strong>Conclusion: </strong>Faricimab treatment resulted in significant improvements in visual acuity and anatomical outcomes in both treatment-naïve and recalcitrant DME eyes, highlighting its potential as a valuable therapeutic option in diverse clinical settings. Further real-world studies are warranted to establish long-term efficacy and safety.</p>","PeriodicalId":93945,"journal":{"name":"Clinical ophthalmology (Auckland, N.Z.)","volume":"19 ","pages":"269-277"},"PeriodicalIF":0.0,"publicationDate":"2025-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11776507/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143070173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Application of the 2021 AAPOS Guidelines in Clinics with Revision and Validation of SPOT Referral Criteria.","authors":"Rui Li, Qi Yan, Xiao Lin, Zhujian Wu, Hui Zhu, Wei Guo, Peibin Zhang, Feidi Zuo, Ziyan Wu, Hu Liu, Dan Huang","doi":"10.2147/OPTH.S488084","DOIUrl":"https://doi.org/10.2147/OPTH.S488084","url":null,"abstract":"<p><strong>Purpose: </strong>This study aims to validate and revise the Spot Vision Screener referral criteria for detecting amblyopia risk factors (ARFs), visually significant refractive error (VSRE), and amblyopia.</p><p><strong>Methods: </strong>In clinics, we gathered data from children aged 12 months to 7 years. The validity of the cut-off values was assessed using receiver operating characteristic (ROC) curves, with cycloplegic retinoscopy serving as a reference. These results were compared to the age-based 2021 AAPOS diagnostic thresholds. Additionally, this study validated previously reported referral criteria within its population.</p><p><strong>Results: </strong>The study involved 1103 children (347 below four years; 756 aged four years and above). We established optimal cut-off points for hyperopia, myopia, astigmatism, and anisometropia: +2.13D, -2.88D, -2.88D, and 0.88D for children under four years; +1.88D, -1.88D, -2.13D, and 0.88D for those four years and older, forming the \"Nanjing Referral Criteria\". The Youden index for several existing referral criteria ranged from 0.08 to 0.53 in detecting ARFs & VSRE and from 0.08 to 0.48 for ARFs, VSRE, and amblyopia.</p><p><strong>Conclusion: </strong>The study proposes the \"Nanjing Referral Criteria\" and its modified version with enhanced specificity for the Spot Vision Screener to optimize vision screening in children. Vision screening programs can utilize this validated data to select referral criteria best suited to their local context.</p>","PeriodicalId":93945,"journal":{"name":"Clinical ophthalmology (Auckland, N.Z.)","volume":"19 ","pages":"291-299"},"PeriodicalIF":0.0,"publicationDate":"2025-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11776419/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143070171","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Ultrasound B-Scan for Posterior Segment and Extraocular Evaluation in Ocular Cysticercosis.","authors":"Vaidehi D Bhatt, Kalpana D Bhatt, Deepak C Bhatt, Supriya Dabir, Jay U Sheth, Tos T J M Berendschot, Roel J Erckens, Carroll A B Webers","doi":"10.2147/OPTH.S494536","DOIUrl":"10.2147/OPTH.S494536","url":null,"abstract":"<p><strong>Purpose: </strong>Cysticercosis, caused by Taenia solium larvae, can affect various ocular and extraocular structures, leading to significant morbidity. Ultrasound B-scan imaging plays a pivotal role in diagnosing and classifying cysticercosis lesions. The aim of the study was to describe the ultrasound B-scan characteristics of ocular and extraocular cysticercosis, proposing a classification system based on anatomical localization to enhance understanding and management.</p><p><strong>Patients and methods: </strong>A retrospective study of consecutive cases with intraocular or extraocular cysticercosis was conducted from January 1993 to December 2023 in Mumbai, India. B-scan ultrasound was performed by an experienced imaging specialist. Descriptive statistics were used to summarize demographic characteristics and the proportion of cysticercosis in each anatomical location. Cysticercosis lesions were classified based on anatomical location observed during imaging.</p><p><strong>Results: </strong>Amongst the 56 eyes evaluated, intraocular posterior segment involvement (n=25) and extraocular involvement (n=31) were observed. Extraocular cysticercosis predominantly affected the medial rectus muscle (40%), followed by the inferior rectus (28%), lateral rectus (20%), and superior rectus muscles (12%). Orbital cysts were localized in the posterior extraconal (50%), anterior extraconal (34.33%), and intraconal (16.67%) regions. Intra-vitreous cysticercosis (n=9) exhibited thin-walled cysts with minimal inflammation, progressing to thickened cyst walls in the late stages. Sub-hyaloid cysticercosis (n=8) showed initial thin vitreous detachment, progressing to thickened vitreous adhesions. Sub-retinal cysticercosis (n=9) without retinal detachment indicated early disease, while cases with detachment suggested disease progression.</p><p><strong>Conclusion: </strong>The proposed anatomical classification system based on B-scan ultrasound features provides a structured approach to categorizing cysticercosis lesions, enhancing understanding and management in ophthalmic practice.</p>","PeriodicalId":93945,"journal":{"name":"Clinical ophthalmology (Auckland, N.Z.)","volume":"19 ","pages":"281-290"},"PeriodicalIF":0.0,"publicationDate":"2025-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11776502/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143070178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Propensity Score to Compare Pars Plana Vitrectomy and Scleral Buckling in Retrospective Studies [Letter].","authors":"Giacomo Visioli, Ludovico Alisi, Giuseppe Maria Albanese","doi":"10.2147/OPTH.S517251","DOIUrl":"https://doi.org/10.2147/OPTH.S517251","url":null,"abstract":"","PeriodicalId":93945,"journal":{"name":"Clinical ophthalmology (Auckland, N.Z.)","volume":"19 ","pages":"279-280"},"PeriodicalIF":0.0,"publicationDate":"2025-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11776504/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143070175","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}